Profile picture

Doctor Veneta Dimitrova

University Hospital Alexandrovska, Sofia (Bulgaria)
Membership: ESC Professional Member EACVI Member EAPCI Member HFA Member
Follow
Logo ESC

Contributor content

Predictive value of global longitudinal strain (GLS) in breast cancer patients undergoing trastuzumab-based chemotherapy
Presentation
Predictive value of global longitudinal strain (GLS) in breast cancer patients undergoing trastuzumab-based chemotherapy
Read more
Acute peripartum cardiomyopathy in an young woman: a case of postpartum heart failure and recovery
Presentation
Acute peripartum cardiomyopathy in an young woman: a case of postpartum heart failure and recovery
Read more
Impact of dapagliflozin therapy on survival in heart failure patients with cancer in remission: A gender-based analysis
Presentation
Impact of dapagliflozin therapy on survival in heart failure patients with cancer in remission: A gender-based analysis
Read more
Combination therapy with SGLT2 inhibitor and beta-blocker in patients with HFpEF and atrial fibrillation: impact on nt-proBNP, HS-CRP, e/e′ and functional capacity
Presentation
Combination therapy with SGLT2 inhibitor and beta-blocker in patients with HFpEF and atrial fibrillation: impact on nt-proBNP, HS-CRP, e/e′ and functional capacity
Read more
2-year retrospective single-center study on mortality rate, BMI and hs-CRP correlation and differences in heart failure cohort between male and female sex
Presentation
2-year retrospective single-center study on mortality rate, BMI and hs-CRP correlation and differences in heart failure cohort between male and female sex
Read more
Amyloidosis – still a challenge for diagnosis and treatment
Presentation
Amyloidosis – still a challenge for diagnosis and treatment
Read more
From non-specific symptoms to life-theatening cardiac complication
Presentation
From non-specific symptoms to life-theatening cardiac complication
Read more
Cardiotoxicity due to combined target therapy of malignant melanoma with full recovery after its discontinuation
Presentation
Cardiotoxicity due to combined target therapy of malignant melanoma with full recovery after its discontinuation
Read more

ESC 365 is supported by

novartis Explore sponsored resources